Intrinsic Value of S&P & Nasdaq Contact Us

Insulet Corporation PODD NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
74/100
4/7 Pass
SharesGrow Intrinsic Value
$321.45
+59.5%
Analyst Price Target
$357.25
+77.3%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Insulet Corporation (PODD) has shown exceptional revenue growth over the past 3 years, expanding from $1.3B to $2.7B (average +27.6%/yr). Net income reached $247M, reflecting exceptional earnings expansion at +1482.2%/yr on average. The net profit margin is 9.1%, which is moderate. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 71.6% (high), with a +9.9pp trend over the period. With a $14B market cap and MOAT composite score of 80/100, the company has a strong competitive position.

Criteria proven by this page:

  • GROWTH (100/100, Pass) — proving strong growth momentum
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 24-year history, the company was profitable in 8 of 24 years — a mixed long-term record
  • INCOME (45/100, Partial) — the company is profitable but margin is below 15%
  • MOAT (80/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 74/100 with 4/7 criteria passed.

74/100
SG Score
View full scorecard →
~
VALUE
42/100
Price-to-Earnings & upside
→ IV page
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $3.48
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
80/100
Score: 80/100
GM 71.6% (+9.9pp)
Proven by this page
GROWTH
100/100
Rev +27.6%/yr
NI +1482.2%/yr
Proven by this page
~
INCOME
45/100
Margin 9.1%
$2.7B
Proven by this page
Insulet Corporation Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $2.71B$2.71B$2.07B$1.7B$1.31B
Gross Profit $1.94B$1.94B$1.45B$1.16B$805.6M
Gross Margin 71.6%71.6%69.8%68.3%61.7%
Operating Income $473.9M$473.8M$308.9M$220M$-26.7M
Net Income $247.1M$247.1M$418.3M$206.3M$4.6M
Net Margin 9.1%9.1%20.2%12.2%0.4%
EPS (Diluted) $3.50$3.48$5.66$2.80$0.07
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message